Author Guidelines

Articles submitted to the JAAPI must be original and should not have been published or under consideration for publication elsewhere, except in abstract form in proceedings of conferences or meetings. Only manuscripts that meet professional and scientific standards will be accepted for publication. Review process is one-sided blind on the authors’ side. But after acceptance of papers, the names of the handling Editors and Reviewers will be published on the front page of the article. This new trend started by some European journals is gaining momentum as it gives due credit to the Editors and Reviewers and ensures fair review process.

JAAPI is published as completely Open Access in electronic form (PDF). A few hard copies will be printed for promotional purposes and for display at AAPI Conventions and other professional meetings or for distribution to libraries or dignitaries. There is no article submission fee or publication charges to the authors. Although materials published are copyrighted by the AAPI, others can cite or reproduce figures, schemes and pictures published in JAAPI without paying fee, but by giving due credit to JAAPI. This does not apply for materials reproduced in JAAPI from other journals, which are copyrighted by the original publisher.  

Types of Articles JAAPI Accepts:

Original Research Articles: These describe original scientific or clinical research conducted on in vitro or animal models or human subjects after obtaining approval by the concerned institutional animal care and use committees (IACUC) or human subjects research review boards (IRB). The research should comply with the guidelines and regulations of US Public Health Service (PHS). The original research articles can be 3,000 to 4,000 words in length, excluding title page, abstract, legends and references. Maximum 7 figures or tables are allowed. Additional figures or tables need to be justifiable for the article. Supplemental Information (SI) containing data and text, such as methods, are allowed for deposition.

Review Articles: The review articles can address any contemporary issue in medical or clinical sciences, or healthcare, including epidemiology, and policy, regulatory and legislative issues. The reviews should provide analysis of the topics but should not be just presenting catalog of information. The review articles should be balanced and should cite literature without bias. The review articles can be 3,000 to 5,000 words, excluding title page, abstract, references, and legends. Not over 7 figures and tables combined are accepted. There is no limit on the number of references, but they should be recent and relevant ones. Review articles exceeding these limits will be considered if they are justifiable and provide significant in-depth and useful information.

Clinical Studies: Clinical studies can be observational or retrospective analysis of data or prospective randomized studies. All clinical studies should be conducted as per the regulations and guidelines, documenting informed consent, protection of research subjects, inclusion of minorities etc., following the guidelines of the US Public Health Service. Rigorous statistical analysis should be followed. Raw data should be provided for analysis if required. These articles can be up to 5,000 words, excluding title page, abstract, tables, legends, and references. The maximum number of figures or tables are 7 to 10 combined. Additional figures or tables should be justifiable for the study. Supplemental Information (SI) is allowed for deposition.

Brief Reports: Brief reports of contemporary issues of high significance are accepted to disseminate information. These reports are up to 1,500 words in length, excluding title page, abstract, legends and references. About 4 tables or figures combined are permitted. Maximum 20 references are allowed.

Letters to the Editor: Letters to the editors on topics of high importance or on the articles published in JAAPI are welcome. These should be focused and carry significant take home message, rather than a simple presentation of one’s own perspective on the topic. Limit submissions to 600 words, with up to 6 references and a maximum of 2 small tables or figures. The authorship should be limited to 2 or 3. No abstracts are allowed.

Articles on Diagnosis and Treatment Review: Article describing latest methods, approaches and technologies in diagnosis and treatment can be up to 2,000 words, excluding title page, abstract, references, and legends. Figures and tables should be limited to five combined.

Case Studies or Clinical Challenges: Case presentation with about 300 to 400 words, followed by discussion of 500-600 words, 1-2 small figures, and less than 10 references, are welcome. The authorship should be limited to 3 unless it involves trainees. Proof of patient consent should be provided, if needed.

Perspectives on Contemporary or Controversial Topics: These should be thought-provoking with intuitive analysis rather than presentation of facts. Some speculation and hypothesis are permitted provided they are supported by rational analytical base. These articles can be up to 2,500 words, excluding title page, abstract, legends and references. Less than 3 tables or figures combined are allowed. References should be limited to the required ones.

Commentaries on Published Papers: Commentaries on published papers are accepted if they provide a significant perspective or missed findings in the original publications. These can either positively or negatively affect the original publication. But the emphasis is how the original publication can affect clinical practice or evidence-based medicine. These can be up to 1,200 words in length with one or two figures or tables, and limited references. No abstract is allowed. Authors can provide bullet points of highlights. Authorship should be limited to one or two.

Bench-to-Bedside or Bedside-to-Bench: Authors can take laboratory findings to clinical settings or bring clinical dilemmas to laboratory research. Special emphasis should be put on moving the subject from bench to bedside or vice versa. This type of article can be up to 1,200 words in length, excluding title page, abstract, legends and references. Not over 3 tables or figures combined are allowed. References should be limited to the required ones.

Review of Books Authored by AAPI Community: This will be limited to books on topics related to medicine and healthcare and related fields, but not to books on other subjects. Both printed and eBooks published by traditional publishers or on self-publishing platforms and bearing ISBN numbers will be eligible for review. The review should be written by an expert in the field, not the author. The review should be about 700 words (not exceeding 800 words), accompanied by an image of the cover page of the book, and a link to the book on Amazon or another online vendor. Please note that JAAPI Editorial Board Members will not write the book reviews. The reviews will not be subject to peer-review but will be reviewed and edited by the editorial board members.

Disclosures: All authors should disclose industry relations, including speaker’s bureau, research grants, travel funds, relevant stocks over $10,000 owned by them or their immediate family members, etc., which can be construed as conflicting with the content of the article being submitted. When in doubt whether a particular industry relation is a conflict, the authors should consult the editorial office.

References Style: JAAPI follows the same style as JAMA for presentation of references, which can be found in the following URL. https://www.bibguru.com/c/jama-citation-generator/

Plagiarism and Copyright: When citing a published report or paper, authors should ensure that passages are not reproduced verbatim, as that is considered as plagiarism, even if the source is cited. Authors should rewrite such passages in their own words. This may not apply to definitions or regulatory statements etc., which cannot be altered. JAAPI screens all submitted articles for copyright issues using plagiarism detection software. When figures or schemes from other publications, including previous publications of the authors, are used in the articles, copyright permission to do so should be obtained. It is author’s responsibility to obtain copyright permission through Copyright Clearance Center (https://www.copyright.com/manageAccount.action). Proof of obtaining copyright permission should be provided to JAAPI. For assistance, authors should contact editorial office.

Use of Artificial Intelligence (AI): In line with the mainstream medical journal, JAAPI does not accept papers generated by AI or machines like ChatBots either in full or partially. JAAPI has tools to detect machine generated text. It is the belief of JAAPI that reviews, and other articles submitted should reflect the professional acumen and scholastic expertise of the authors, but not the machines. So, JAAPI strictly forbids the use of AI or AI tools in preparing the articles.

Proprietary Names: While citing names of drugs or medications, authors should avoid brand names and use generic or pharmacological names only.